Open
New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 - Clinical Trial Optional)
National Institutes of Health·Government
AI Summary
The National Institutes of Health is seeking proposals for the development of new glucose control technologies that incorporate AI/ML tools and strategies. The goal is to improve glucose control and reduce the risk of complications associated with diabetes. The solicitation is open to eligible applicants and has a deadline of June 17, 2026.
Full Description
Title: New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 - Clinical Trial Optional)
Agency: National Institutes of Health
Agency Code: HHS-NIH11
Status: posted
Document Type: synopsis
Open Date: 05/07/2026
Close Date: 06/17/2026
CFDA Numbers: 93.847
Opportunity Number: RFA-DK-27-146
Opportunity ID: 359200